Recently, timed-release bromocriptine (Cycloset), a sympatholytic dopamine D 2 receptor agonist, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

Proper treatment for type 2 diabetes is crucial ... carbohydrates in your intestines and lowers your blood sugar levels. Dopamine agonist Cycloset Thought to change levels of the neurotransmitter ...

because they do not cause behavioral signs associated with activation of either normosensitive or supersensitive postsynaptic dopamine D 2 receptors (e.g., increased locomotion in reserpinized ...

For the first time, scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility, according ...

One of the main treatments for movement disorders is a group of drugs called dopamine-receptor agonists, which include cabergoline, ropinirole, bromocriptine and pramipexole. Dopamine-receptor ...

Scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility. PET imaging shows that the brain increases dopamine production when completing cognitively demanding tasks ...

Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...